These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 12113716)

  • 1. [Hospitalized congestive heart failure patients with preserved versus abnormal left ventricular systolic function].
    Martínez-Sellés M; García Robles JA; Prieto L; Frades E; Muñoz R; Díaz Castro O; Almendral J
    Rev Esp Cardiol; 2002 Jun; 55(6):579-86. PubMed ID: 12113716
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hospitalized congestive heart failure patients with preserved versus abnormal left ventricular systolic function: clinical characteristics and drug therapy.
    McDermott MM; Feinglass J; Sy J; Gheorghiade M
    Am J Med; 1995 Dec; 99(6):629-35. PubMed ID: 7503086
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systolic versus diastolic heart failure in community practice: clinical features, outcomes, and the use of angiotensin-converting enzyme inhibitors.
    Philbin EF; Rocco TA; Lindenmuth NW; Ulrich K; Jenkins PL
    Am J Med; 2000 Dec; 109(8):605-13. PubMed ID: 11099679
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Comparative study on characteristics of congestive heart failure patients with preserved versus abnormal left ventricular systolic function and evaluation effects of therapy].
    Zhan H; Tse HF; Cao JM; Lau CP
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2006 Apr; 18(4):210-5. PubMed ID: 16647010
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heart failure in patients with preserved and deteriorated left ventricular ejection fraction.
    Varela-Roman A; Grigorian L; Barge E; Bassante P; de la Peña MG; Gonzalez-Juanatey JR
    Heart; 2005 Apr; 91(4):489-94. PubMed ID: 15772209
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heart failure with preserved left ventricular ejection fraction in patients with acute myocardial infarction.
    Antonelli L; Katz M; Bacal F; Makdisse MR; Correa AG; Pereira C; Franken M; Fava AN; Serrano Junior CV; Pesaro AE
    Arq Bras Cardiol; 2015 Aug; 105(2):145-50. PubMed ID: 26039659
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Differences in clinical profile and outcome in patients with decompensated heart failure and systolic dysfunction or preserved systolic function].
    Macín SM; Perna ER; Címbaro Canella JP; Alvarenga P; Pantich R; Ríos N; Farías EF; Badaracco JR
    Rev Esp Cardiol; 2004 Jan; 57(1):45-52. PubMed ID: 14746717
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical features and prognosis associated with a preserved left ventricular systolic function in a large cohort of congestive heart failure outpatients managed by cardiologists. Data from the Italian Network on Congestive Heart Failure.
    Tarantini L; Faggiano P; Senni M; Lucci D; Bertoli D; Porcu M; Opasich C; Tavazzi L; Maggioni AP
    Ital Heart J; 2002 Nov; 3(11):656-64. PubMed ID: 12506524
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of angiotensin-converting enzyme inhibitors in heart failure with preserved left ventricular systolic function.
    Philbin EF; Rocco TA
    Am Heart J; 1997 Aug; 134(2 Pt 1):188-95. PubMed ID: 9313596
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characteristics, treatments, and outcomes of patients with preserved systolic function hospitalized for heart failure: a report from the OPTIMIZE-HF Registry.
    Fonarow GC; Stough WG; Abraham WT; Albert NM; Gheorghiade M; Greenberg BH; O'Connor CM; Sun JL; Yancy CW; Young JB;
    J Am Coll Cardiol; 2007 Aug; 50(8):768-77. PubMed ID: 17707182
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of Angiotensin Converting Enzyme Inhibitors/Angiotensin Receptors Blockers on Mortality in Acute Heart Failure Patients with Left Ventricular Systolic Dysfunction in the Middle East: Observations from the Gulf Acute Heart Failure Registry (Gulf CARE).
    Al-Zakwani I; Sulaiman K; Al-Lawati JA; Alsheikh-Ali AA; Panduranga P; Al-Habib KF; Al Suwaidi J; Al-Mahmeed W; Al-Faleh H; Elasfar A; Al-Motarreb A; Ridha M; Bulbanat B; Al-Jarallah M; Bazargani N; Asaad N; Amin H
    Curr Vasc Pharmacol; 2018; 16(6):596-602. PubMed ID: 28820057
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of statins, angiotensin-converting enzyme inhibitors, and beta blockers on survival in patients >or=65 years of age with heart failure and preserved left ventricular systolic function.
    Shah R; Wang Y; Foody JM
    Am J Cardiol; 2008 Jan; 101(2):217-22. PubMed ID: 18178410
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence, clinical characteristics, quality of life, and prognosis of patients with congestive heart failure and isolated left ventricular diastolic dysfunction.
    Badano LP; Albanese MC; De Biaggio P; Rozbowsky P; Miani D; Fresco C; Fioretti PM
    J Am Soc Echocardiogr; 2004 Mar; 17(3):253-61. PubMed ID: 14981424
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Doppler-echocardiographic indices of diastolic function in heart failure admissions with preserved left ventricular systolic function.
    Cahill JM; Horan M; Quigley P; Maurer B; McDonald K
    Eur J Heart Fail; 2002 Aug; 4(4):473-8. PubMed ID: 12167386
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Temporal trends in pharmacotherapy for congestive heart failure at an academic medical center: 1990-1995.
    Rich MW; Brooks K; Luther P
    Am Heart J; 1998 Mar; 135(3):367-72. PubMed ID: 9506320
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical presentation, management, and in-hospital outcomes of patients admitted with acute decompensated heart failure with preserved systolic function: a report from the Acute Decompensated Heart Failure National Registry (ADHERE) Database.
    Yancy CW; Lopatin M; Stevenson LW; De Marco T; Fonarow GC;
    J Am Coll Cardiol; 2006 Jan; 47(1):76-84. PubMed ID: 16386668
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antithrombotic therapy is associated with better survival in patients with severe heart failure and left ventricular systolic dysfunction (EPICAL study).
    Echemann M; Alla F; Briançon S; Juillière Y; Virion JM; Mertès PM; Villemot JP; Zannad F; Aliot E; Breton Ch; KhalifE K; Neimann JL; Allam S; Admant P; Baille N; Bellanger P; D'Hôtel R; Dambrine P; Dodet JF; Graille M; Kessler M; Rebeix G; Royer ; Saulnier JP; Thisse JY; Trutt B; Vidal P; Vuillemin MCh; Delahaye ; Ducimetière P; Fagnani F; Guize L;
    Eur J Heart Fail; 2002 Oct; 4(5):647-54. PubMed ID: 12413509
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical characteristics and medium-term prognosis of patients with heart failure and preserved systolic function. Do they differ in systolic dysfunction?].
    Ojeda S; Anguita M; Muñoz JF; Rodríguez MT; Mesa D; Franco M; Ureña I; Vallés F
    Rev Esp Cardiol; 2003 Nov; 56(11):1050-6. PubMed ID: 14622535
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Congestive heart failure with preserved left ventricular systolic function after acute myocardial infarction: clinical and prognostic implications.
    Møller JE; Brendorp B; Ottesen M; Køber L; Egstrup K; Poulsen SH; Torp-Pedersen C;
    Eur J Heart Fail; 2003 Dec; 5(6):811-9. PubMed ID: 14675860
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systolic function, readmission rates, and survival among consecutively hospitalized patients with congestive heart failure.
    McDermott MM; Feinglass J; Lee PI; Mehta S; Schmitt B; Lefevre F; Gheorghiade M
    Am Heart J; 1997 Oct; 134(4):728-36. PubMed ID: 9351741
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.